{
    "organizations": [],
    "uuid": "551e0e52771ee1f597ec4c96ddda25ac02c2310c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/idUSL8N1RX15F",
    "ord_in_thread": 0,
    "title": "BRIEF-Biomed Prelim. FY Net Profit At 0.6 Mln Zlotys",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - Biomed-Lublin Wytwornia Surowic i Szczepionek SA:\n* REPORTED ON THURSDAY PRELIMINARY FY NET PROFIT OF 0.6 MILLION ZLOTYS\n* PRELIM. FY EBITDA 11.1 MILLION ZLOTYS ON PRELIM. REVENUE OF 31.2 MILLION ZLOTYS\n* FY FINANCIAL RESULTS AFFECTED BY ONE-OFF EVENTS, INCLUDING SALE OF TRADEMARK AND OTHER RIGHTS TO LAKCID PRODUCTS AND SETTLEMENT OF REAL ESTATE SALE TRANSACTIONS IN MIELEC\nSource text for Eikon:\nFurther company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-20T16:13:00.000+03:00",
    "crawled": "2018-04-21T18:29:51.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "wytwornia",
        "surowic",
        "szczepionek",
        "sa",
        "reported",
        "thursday",
        "preliminary",
        "fy",
        "net",
        "profit",
        "million",
        "zloty",
        "prelim",
        "fy",
        "ebitda",
        "million",
        "zloty",
        "prelim",
        "revenue",
        "million",
        "zloty",
        "fy",
        "financial",
        "result",
        "affected",
        "event",
        "including",
        "sale",
        "trademark",
        "right",
        "lakcid",
        "product",
        "settlement",
        "real",
        "estate",
        "sale",
        "transaction",
        "mielec",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}